| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0135714101922724 | -0.16410613 |
| NSC 748902 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] | 0.0135714101922724 | -0.28672529 |
| NSC 750050 | Null | 0.0135714101922724 | -0.18547752 |
| NSC 755442 | Null | 0.0135714101922724 | 0.037907355 |
| NSC 762346 | Null | 0.0135714101922724 | -0.098104307 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.0135714101922724 | -0.27448581 |
| NSC 129757 | Null | 0.0139796580235792 | 0.19896628 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0139796580235792 | -0.14545455 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0139796580235792 | -0.29818811 |
| NSC 258168 | 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- | 0.0139796580235792 | -0.083510929 |